100 related articles for article (PubMed ID: 2156059)
1. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations.
Thompson AK; Fisher SK
J Pharmacol Exp Ther; 1990 Feb; 252(2):744-52. PubMed ID: 2156059
[TBL] [Abstract][Full Text] [Related]
2. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
Fisher SK; Snider RM
Mol Pharmacol; 1987 Jul; 32(1):81-90. PubMed ID: 3600615
[TBL] [Abstract][Full Text] [Related]
3. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
Fisher SK
Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
Xu J; Chuang DM
J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
[TBL] [Abstract][Full Text] [Related]
5. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
Masters SB; Quinn MT; Brown JH
Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182
[TBL] [Abstract][Full Text] [Related]
6. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
Hu J; Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation.
Fisher SK; Domask LM; Roland RM
Mol Pharmacol; 1989 Feb; 35(2):195-204. PubMed ID: 2537457
[TBL] [Abstract][Full Text] [Related]
8. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function.
Feigenbaum P; El-Fakahany EE
J Pharmacol Exp Ther; 1985 Apr; 233(1):134-40. PubMed ID: 3981451
[TBL] [Abstract][Full Text] [Related]
9. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
Cioffi CL; el-Fakahany EE
J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226
[TBL] [Abstract][Full Text] [Related]
10. Organophosphate-induced alterations in muscarinic receptor binding and phosphoinositide hydrolysis in the human SK-N-SH cell line.
Katz LS; Marquis JK
Neurotoxicology; 1992; 13(2):365-78. PubMed ID: 1331918
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of muscarinic stimulated hippocampal cell firing is related to phosphoinositide hydrolysis and inhibited by lithium.
Pontzer NJ; Crews FT
J Pharmacol Exp Ther; 1990 Jun; 253(3):921-9. PubMed ID: 2162952
[TBL] [Abstract][Full Text] [Related]
12. Preferential coupling of cell surface muscarinic receptors to phosphoinositide hydrolysis in human neuroblastoma cells.
Thompson AK; Fisher SK
J Biol Chem; 1991 Mar; 266(8):5004-10. PubMed ID: 1848233
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of homologous desensitization and internalization of muscarinic receptors in primary cultures of neonatal corticostriatal neurons.
Eva C; Gamalero SR; Genazzani E; Costa E
J Pharmacol Exp Ther; 1990 Apr; 253(1):257-65. PubMed ID: 2158546
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition.
Baumgold J; White T
Biochem Pharmacol; 1989 May; 38(10):1605-16. PubMed ID: 2471534
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptor-mediated translocation of calmodulin in SK-N-SH human neuroblastoma cells.
Mangels LA; Gnegy ME
Mol Pharmacol; 1990 Jun; 37(6):820-6. PubMed ID: 2359403
[TBL] [Abstract][Full Text] [Related]
17. Reduction of muscarinic receptor density and of guanine nucleotide-stimulated phosphoinositide hydrolysis in human SH-SY5Y neuroblastoma cells following long-term treatment with 12-O-tetradecanoylphorbol 13-acetate or mezerein.
Cioffi CL; Fisher SK
J Neurochem; 1990 May; 54(5):1725-34. PubMed ID: 2157816
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of phosphoinositide and cyclic GMP responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells. Correlation with down-regulation of cell surface receptors.
Cioffi CL; el-Fakahany EE
Biochem Pharmacol; 1989 Jun; 38(11):1827-34. PubMed ID: 2544180
[TBL] [Abstract][Full Text] [Related]
19. Agonist-induced desensitization of cholinergically stimulated phosphoinositide breakdown is independent of endogenously activated protein kinase C in HT-29 human colon carcinoma cells.
Kopp R; Mayer P; Pfeiffer A
Biochem J; 1990 Jul; 269(1):73-8. PubMed ID: 2165399
[TBL] [Abstract][Full Text] [Related]
20. Heterologous desensitization of both phosphoinositide and Ca2+ signaling in SH-SY5Y neuroblastoma cells: a role for intracellular Ca2+ store depletion?
Willars GB; Nahorski SR
Mol Pharmacol; 1995 Mar; 47(3):509-16. PubMed ID: 7700249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
